PHARMCO II ApS: Financial statements 2017
CVR: 25202899
PHARMCO II ApS (CVR 25202899) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -18,126 and a net result of DKK 2,785,070 compared with DKK 2,271,044 the year before. Equity amounted to DKK 59,493,125. The solvency ratio was 98.7%.
- Gross Profit
- -18,126 kr.
- Profit/Loss
- 2,785,070 kr.
- Equity
- 59,493,125 kr.
- Total Assets
- 60,247,237 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -18 t. | 2.8 mio. | 59.5 mio. | - |
| 2016 | - | -21 t. | 2.3 mio. | 56.7 mio. | - |
| 2015 | - | 17.8 mio. | 3 mio. | - | 37 |
| 2014 | - | -21 t. | 1.8 mio. | 52.8 mio. | 34 |
| 2013 | - | -19 t. | 3.6 mio. | 51.1 mio. | - |
Find more companies like PHARMCO II ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
PHARMCO II ApS has published its annual report for 2016. Gross profit came to DKK -20,625, and the net result was DKK 2,271,044.
About PHARMCO II ApS
PHARMCO II ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2000. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin and PharmCo III ApS. In 2025, the company reported a gross profit of DKK -56,000 and a net result of DKK 34,432,000 compared with DKK 7,096,622 the year before. Equity amounted to DKK 107,079,000.
